Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ABBVIE-INC-12136589/news/Abbvie-gibt-Ergebnisse-von-Phase-3-Studien-mit-SKYRIZI-Risankizumab-bekannt-41744661/?utm_source=whatsapp&utm_medium=social&utm_campaign=share